R, A., & M, G. (2025). Pretransplantation optimisation for unresectable colorectal liver metastases: The TransMet trial - Authors' reply. Lancet (London, England), 405(10488), 1466. https://doi.org/10.1016/S0140-6736(25)00660-9
Chicago Style (17th ed.) CitationR, Adam, and Gelli M. "Pretransplantation Optimisation for Unresectable Colorectal Liver Metastases: The TransMet Trial - Authors' Reply." Lancet (London, England) 405, no. 10488 (2025): 1466. https://doi.org/10.1016/S0140-6736(25)00660-9.
MLA (9th ed.) CitationR, Adam, and Gelli M. "Pretransplantation Optimisation for Unresectable Colorectal Liver Metastases: The TransMet Trial - Authors' Reply." Lancet (London, England), vol. 405, no. 10488, 2025, p. 1466, https://doi.org/10.1016/S0140-6736(25)00660-9.